| Dr Andre Chartier, MD | |
|
620 John Paul Jones Cir, Portsmouth, VA 23708-2111 | |
| (757) 953-1128 | |
| Not Available |
| Full Name | Dr Andre Chartier |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 620 John Paul Jones Cir, Portsmouth, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134414527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 2018-02774 (North Carolina) | Primary |
| Entity Name | Virtual Radiologic Professionals Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932342029 PECOS PAC ID: 4981608817 Enrollment ID: O20061208000303 |
News Archive
Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.
Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.
In rural areas around the country, in the period 2007 to 2016, private insurance claim lines with opioid abuse and dependence diagnoses were found in every age group from 13- 18 years to over 80 years, and in urban areas, in every age group from 13-18 years to 71-80 years.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has received notification from the European Patent Office (EPO) that Advaxis patent application 98957980.0 titled "Bacterial Vaccines Comprising Auxotrophic, Attenuated Strains of Listeria Expressing Heterologous Antigens," has been granted and will be issued as patent #1032417
› Verified 3 days ago
| Entity Name | Renaissance Imaging Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487608931 PECOS PAC ID: 7315841756 Enrollment ID: O20171212000738 |
News Archive
Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.
Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.
In rural areas around the country, in the period 2007 to 2016, private insurance claim lines with opioid abuse and dependence diagnoses were found in every age group from 13- 18 years to over 80 years, and in urban areas, in every age group from 13-18 years to 71-80 years.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has received notification from the European Patent Office (EPO) that Advaxis patent application 98957980.0 titled "Bacterial Vaccines Comprising Auxotrophic, Attenuated Strains of Listeria Expressing Heterologous Antigens," has been granted and will be issued as patent #1032417
› Verified 3 days ago
| Entity Name | Golden State Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144872052 PECOS PAC ID: 1254761315 Enrollment ID: O20200918001360 |
News Archive
Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.
Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.
In rural areas around the country, in the period 2007 to 2016, private insurance claim lines with opioid abuse and dependence diagnoses were found in every age group from 13- 18 years to over 80 years, and in urban areas, in every age group from 13-18 years to 71-80 years.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has received notification from the European Patent Office (EPO) that Advaxis patent application 98957980.0 titled "Bacterial Vaccines Comprising Auxotrophic, Attenuated Strains of Listeria Expressing Heterologous Antigens," has been granted and will be issued as patent #1032417
› Verified 3 days ago
| Entity Name | St Paul Place Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497707681 PECOS PAC ID: 7719882943 Enrollment ID: O20240206002389 |
News Archive
Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.
Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.
In rural areas around the country, in the period 2007 to 2016, private insurance claim lines with opioid abuse and dependence diagnoses were found in every age group from 13- 18 years to over 80 years, and in urban areas, in every age group from 13-18 years to 71-80 years.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has received notification from the European Patent Office (EPO) that Advaxis patent application 98957980.0 titled "Bacterial Vaccines Comprising Auxotrophic, Attenuated Strains of Listeria Expressing Heterologous Antigens," has been granted and will be issued as patent #1032417
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andre Chartier, MD 620 John Paul Jones Cir, Portsmouth, VA 23708-2111 Ph: (469) 879-1640 | Dr Andre Chartier, MD 620 John Paul Jones Cir, Portsmouth, VA 23708-2111 Ph: (757) 953-1128 |
News Archive
Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.
Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.
In rural areas around the country, in the period 2007 to 2016, private insurance claim lines with opioid abuse and dependence diagnoses were found in every age group from 13- 18 years to over 80 years, and in urban areas, in every age group from 13-18 years to 71-80 years.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has received notification from the European Patent Office (EPO) that Advaxis patent application 98957980.0 titled "Bacterial Vaccines Comprising Auxotrophic, Attenuated Strains of Listeria Expressing Heterologous Antigens," has been granted and will be issued as patent #1032417
› Verified 3 days ago
Michael Edwin Fenton, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 | |
Alexander F Kelley, DO Radiology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-3029 | |
Dr. Glenn Andrew Rauscher, DO Radiology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 | |
Eric Palmer Jones, MD Radiology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-7550 | |
Dr. Christopher Dac Nguyen, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1143 | |
Cameron Richardson Kendall, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 |